作者：
Fumio,Sawano [1]
;
Nozomu,Kamei [2]
;
Mitsue,Miyahara [3]
;
Kyoko,Kobuke [4]
;
Shuhei,Nakanishi [5]
;
Chihiro,Nagano [6]
;
Hideki,Nojima [7]
;
Shusaku,Maeda [8]
;
Hiroshi,Watanabe [9]
;
Rui,Kishimoto [10]
;
Mami,Yamashita [6]
;
Aya,Hamaoka [11]
;
Kana,Mukai [12]
;
Tomoko,Tsuboi [6]
;
Hisayoshi,Mochizuki [3]
;
Reiko,Nakashima [13]
;
Yu,Sakashita [14]
;
Hisaaki,Morishita [15]
;
Tadahiro,Kitamura [16]
作者单位：
Sawano Thyroid and Diabetes Specialized Clinic, 3-8-5 Oote-machi, Naka-ku, Hiroshima, 730-0051 Japan.
[1]
Department of Endocrinology and Metabolism, Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital, Hiroshima, Japan.
[2]
Department of Diabetes and Endocrinology, Hiroshima Prefectural Hospital, Hiroshima, Japan.
[3]
Ootemachi Kobuke Medical Clinic, Hiroshima, Japan.
[4]
Department of Diabetes, Metabolism and Endocrinology, Kawasaki Medical School, Kurashiki, Okayama Japan.
[5]
Department of Endocrinology and Diabetes, Hiroshima University Hospital, Hiroshima, Japan.
[6]
Nojima Internal Medicine Clinic, Hiroshima, Japan.
[7]
Maeda Medical Clinic, Hiroshima, Japan.
[8]
Department of Endocrinology, Tsuchiya General Hospital, Hiroshima, Japan.
[9]
Department of Internal Medicine, Chugoku Rosai Hospital, Kure, Hiroshima, Japan.
[10]
Diabetes Center, Hiroshima General Hospital, Hatsukaichi, Hiroshima, Japan.
[11]
Harada Hospital, Hiroshima, Japan.
[12]
Senda Medical Clinic, Hiroshima, Japan.
[13]
Department of Internal Medicine, Yoshijima Hospital, Hiroshima, Japan.
[14]
Department of Diabetes, Hiroshima Kyoritsu Hospital, Hiroshima, Japan.
[15]
Metabolic Signal Research Center, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Gunma Japan.
[16]
DOI
10.1007/s13340-021-00492-8
PMID
34567919
发布时间
2022-04-27
换一批
换一批
